Randomised Controlled Trial of sedation for colonoscopy: Entonox versus Midazolam/Fentanyl
| ISRCTN | ISRCTN81142957 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN81142957 |
| Protocol serial number | N0084160165 |
| Sponsor | Department of Health |
| Funder | The North and South Bank Research and Development Consortium (UK) - NHS R&D Support Funding |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 25/06/2010
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Graeme Duthie
Scientific
Scientific
Acadmemic Surgical Unit
Hull and East Yorkshire Hospitals (NHS) Trust
Castle Hill Hospital
Hull
HU16 5JQ
United Kingdom
| Phone | +44 (0)1482 623247 |
|---|---|
| G.S.Duthie@hull.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Does nitrous oxide (Entonox) provide better pain relief than the conventional intravenous sedation during colonoscopy |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Surgery: Sedation |
| Intervention | Prospective randomised controlled study. Pilot study initially involving 100 patients to determine statistical power. Pts will be randomised using the sealed envelope method of block randomisation. Patients randomised to the entonox group will be taught methods of use. Patients will be shown the visual analogue score for pain and asked to mark them. Those randomised to conventional intravenous sedation will be informed of same and will undergo colonoscopy using standard intravenous sedation protocols. Entonox group encouraged to inhale the nitrous oxide for a full 60 seconds initially and then as and when required throughout procedure. Post colonoscopy both groups will be asked to indicate pain using visual analogue scale in the recovery. |
| Intervention type | Procedure/Surgery |
| Primary outcome measure(s) |
Pain score assessed by VAS |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 10/02/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 100 |
| Key inclusion criteria | All patients undergoing elective colonoscopy would be prospective participants. |
| Key exclusion criteria | 1. History of chronic respiratory disease 2. History of colonic resection 3. Intolerance to the drugs 4. Patients with pre-existing adbominal or perianal pain 5. Unwilling participants |
| Date of first enrolment | 11/03/2005 |
| Date of final enrolment | 10/02/2006 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Acadmemic Surgical Unit
Hull
HU16 5JQ
United Kingdom
HU16 5JQ
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Abstract results | conference proceedings | 01/04/2009 | No | No |